Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
Biology Project description: This is a joint PhD programme between Swansea University and Université Grenoble Alpes. Gliomas are brain tumours characterized by the invasion of the surrounding healthy
-
the protein prostate specific antigen levels, can be used to improve active surveillance by reducing the number of men who undergo surgery or radiotherapy needlessly. Working with the Trial Manager, you will
-
& Pharmaceutical Sciences, Kings College London and be part of the Molecular Breast Cancer Genetics Group led by Professor Elinor Sawyer. Radiotherapy is routinely used in the treatment of breast cancer to reduce
-
Genetics Group led by Professor Elinor Sawyer. Radiotherapy is routinely used in the treatment of breast cancer to reduce the risk of recurrence. However, despite radiotherapy some patients still experience
-
? Not funded by an EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description Mathematics: Fully Funded SUPRS PhD Scholarship: Mathematical Computational
-
statisticians, epidemiologists, oncologists, a surgeon, a radiotherapy physicist, and DPhil students. To be considered you will hold a PhD in statistics or a closely related field. You will have experience
-
contribute to ground-breaking research aimed at enhancing the effectiveness of radiotherapy treatments. Our focus lies in developing innovative approaches to sensitize tumor cells to radiotherapy, with
-
of this project is to develop anticancer molecularly targeted radiotherapy agents (theranostics) for the imaging and treatment of cancer. The focus of the project will be on specific organelle targeting with
-
-oncology/ATMP trial clinic – Cardiff Cancer Research Hub* University: academic Direct Clinical Care (DCC) Immuno-oncology trial clinic or Radiotherapy planning (depending on oncology speciality of appointee
-
project that includes an international, multi-centre, clinical trial collecting pre-treatment blood samples and extensive, longitudinal data from cancer patients receiving potentially curative radiotherapy